Furthermore, Western blot findings reveal that RP-6306 treatment activates the inflammatory MAPK pathway within pancreatic cancer cells, evidenced by elevated phosphorylation of p38 MAPK, JNK, and ERK (Fig. 3L). This evidence concerns the gene MAPK8 and pancreatic neoplasm.